The scientific process relies on people’s willingness to publish data-driven findings. Turning to the legal system to adjudicate the merit of evidence-based assertions in the scientific literature leads us down a dangerous path.
Those of us involved in research don’t consider the possibility that we might need to defend a project’s findings in court. This item refers to recent cases where that is exactly what happened and why we all should be troubled.
.
In a case reported on in January by STAT News, Harvard researcher Pieter Cohen had to defend himself in US federal court over a study that he had coauthored in the journal Drug Testing and Analysis (Drug Test. Anal. 8, 328–333, 2016). The study had analyzed popular supplements and looked for the presence of β-methylphenylethylamine (BMPEA), a compound that is chemically similar to amphetamines. It found BMPEA in six weight-loss products made by the company Hi-Tech Pharmaceuticals. The paper noted that the safety and efficacy of BMPEA had not been proven in human studies.
.